Description
Tirzepatide is a novel, dual GLP-1 and GIP receptor agonist designed to improve metabolic health by regulating blood glucose levels, insulin sensitivity, and weight management. This synthetic peptide has gained significant attention for its unique mechanism of action, which activates both the glucagon-like peptide-1 (GLP-1) receptor and the glucose-dependent insulinotropic peptide (GIP) receptor. Researchers are particularly interested in its potential to treat type 2 diabetes, obesity, and other metabolic disorders.
Tirzepatide works by stimulating the GLP-1 receptor to enhance insulin secretion in response to glucose, while simultaneously activating the GIP receptor, which improves glucose metabolism and insulin sensitivity. In addition to controlling blood sugar levels, Tirzepatide also reduces appetite and slows gastric emptying, making it an effective tool for weight management. The combined activation of both receptors has shown promising results in improving overall metabolic health, including fat loss, glucose regulation, and appetite control, which is why Tirzepatide is being studied as a powerful treatment for metabolic syndrome and related conditions.
The 10mg vial of Tirzepatide is ideal for researchers initiating studies on GLP-1 and GIP receptor modulation, metabolic diseases, and weight management. This vial size is suitable for in vitro studies, receptor binding assays, and early-stage in vivo experiments in animal models, providing sufficient material for focused research without requiring larger quantities.
Progression Peptides offers Tirzepatide as a high-purity lyophilized powder, with third-party purity verification ensuring the peptide meets rigorous research standards. The lyophilized form preserves the peptideâs stability and bioactivity when handled and stored according to recommended guidelines.
Reconstitution: Reconstitute with bacteriostatic water, allowing it to dissolve gently without agitation. The solution should remain clear and free from visible particles.
Storage: Store the lyophilized peptide at -20°C. Once reconstituted, refrigerate at 2-8°C and use within 30 days.
For research purposes only. Not for human consumption or veterinary use. Sold exclusively for laboratory and in vitro research.

















Reviews
There are no reviews yet.